Summary
The fund seeks maximum capital appreciation in the long term by investing in small-size companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team seeks to invest in companies demonstrating growth potential.
The team favors companies that possess franchise characteristics, are benefiting from an accelerating profit cycle a
Link
Directors
Dec 14, 2023- Coleen Downs Dinneen
- Gregory K. Ramirez
- Peter M. Lebovitz
- Peter E. Sundman
- Gail L. Hanson
- Bonnie L. Howard
- William J. Kelly
Chief Compliance Officer
- Jill M. Demski
Fund Manager(s)
- Craigh Cepukenas
- James Hamel
- Matthew Kamm
- Jason White
- Jay Warner
Price
Company Name |
Holding |
| Halozyme Therapeutics, Inc. | 5.82 % |
| Guidewire Software, Inc. | 5.23 % |
| Lattice Semiconductor Corp. | 4.72 % |
| Ascendis Pharma A/S | 4.54 % |
| Argenx SE | 4.38 % |
| SPX Technologies, Inc. | 3.65 % |
| Twist Bioscience Corp. | 3.24 % |
| Tyler Technologies, Inc. | 2.97 % |
| MACOM Technology Solutions Holdings, Inc. | 2.94 % |
| Novanta, Inc. | 2.82 % |
| More |
Documents
Performance
YTD
4.4%
3 Year
-31.19%
5 Year
7.67%
Best
52.36%
2020
Worst
-29.6%
2022
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 9.4% | 7.6% | -18.1% | -5% | -15% | 23.1% | 7.6% | - | - | - |
| Q2 | -6.4% | 1.2% | -21.5% | 16.4% | 37.3% | 5.9% | 10% | 5.7% | - | - |
| Q3 | - | -8% | 3.3% | -11.3% | 2.7% | -4% | 9.6% | 3.7% | - | - |
| Q4 | - | 10.2% | 6% | -7.1% | 14% | 1.9% | -18.6% | 4.9% | - | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -2.7% | 9.9% | 2.4% | -8.9% | - | - | - | - | - | - | - | - |
| 2023 | 8.4% | -0.9% | 0.2% | -6.3% | 1.7% | 6.2% | 4.3% | -4.8% | -7.3% | -9.9% | 11.2% | 9% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4% | 10% | -30% | -18% | 52% | 30% | 2% | 0% | 0% | 0% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| APDSX | 4% | 10% | -30% | -18% | 52% | 30% | 2% | - | - | - |
| Russell 2000 | - | - | -32% | 2% | 34% | 28% | -10% | 21% | 10% | -2% |
| Alpha | 4% | 10% | 2% | -21% | 19% | 2% | 12% | - | - | - |